loading page

Use of polysaccharide hemostatic agent (HaemoCerTM) in breast cancer surgery to reduce postoperative complications: a randomized controlled trial
  • +5
  • Veronica Falcone,
  • Pavla Krotka,
  • Christine Deutschmann,
  • Sabine Danziger,
  • Theresa Reischer,
  • Georg Pfeiler,
  • Christian Singer,
  • Marianne Koch
Veronica Falcone
Medical University of Vienna

Corresponding Author:[email protected]

Author Profile
Pavla Krotka
Medical University of Vienna
Author Profile
Christine Deutschmann
Medical University of Vienna
Author Profile
Sabine Danziger
Medical University of Vienna
Author Profile
Theresa Reischer
Medical University of Vienna
Author Profile
Georg Pfeiler
Medical University of Vienna
Author Profile
Christian Singer
Medical University of Vienna
Author Profile
Marianne Koch
Medical University of Vienna
Author Profile

Abstract

Objective: To evaluate whether the application of polysaccharide hemostatic agent during breast conservative surgery affects the perioperative period. Design: Randomized, masked, single-center study Setting: Breast-care unit, at the Medical University of Vienna Population: Pre- and postmenopausal women affected by intraductal or invasive breast cancer, undergoing breast conservative surgery. Methods: Women were randomly assigned polysaccharide hemostatic agent or not, intraoperatively. Main outcome measures: Primary outcome was the total volume of postoperative drained fluid from the surgical site. Secondary outcomes were number of days until drain removal, rate of immediate postoperative surgical site infection, and total volume of postoperative drained fluid from the surgical site. Results: Patients in the intervention group had significantly higher drainage output volumes compared to the control group 85ml (IQR 46.25-110) vs. 50ml (IQR 30-75), respectively; (p=0.003). A univariable linear regression analyses, showed a significant association between the surgical specimen and the primary outcome (p<0.001). After multivariable analysis, the use of absorbable polysaccharide hemostatic product was no longer significantly associated with a higher drainage output and only the size of the surgical specimen remained a significant predictor. The number of days until drainage removal and the postoperative seroma formation were higher in the intervention group, (p=0.004) and (p=0.003), respectively. Conclusion:In our study, intraoperative application of polysaccharide hemostatic agent during breast-conserving surgery did not decrease postoperative fluid production.Only the size of the surgical specimen was significantly associated with postoperative drainage volume. Tweetable abstract:Intraoperative polysaccharide hemostatic does not reduce the volume of postoperative fluid drained after breast conservative surgery